TNFSF10 and central nervous system cancer: Genetically modified MSCs expressing tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) exhibited targeted delivery and local production of TRAIL at glioma tumor site (Menon et al., 2009).